检索结果-南通市图书馆

Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes：A Randomized, Double-blind, Multicenter Clinical Trial

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Chinese Medical Journal 2017年第14期130卷 1639-1647页

作者： Xi Wang Dan HU Song Dang He Huang Cong-Xin Huang Ming-Jie Yuan Yan-Hong Tang qing-shan zheng Fang Yin Shu Zhang Bo-Li Zhang Run-Lin Gao Department of Cardiology Cardiovascular Research Institute Renmin Hospital of Wuhan University Wuhan University Wuhan Hubei 430060 China Department of Cardiology Cardiovascular Research Institute Renmin Hospital of Wuhan University Wuhan University Wuhan Hubei 430060 China Department of Experimental Cardiology Masonic Medical Research Laboratory Utica NY 13501 USA Center for Drug Clinical Research Shanghai University of Traditional Chinese Medicine Shanghai 201203 China National Center for Cardiovascular Disease Fuwai Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100037 China State Key Laboratory of Modern Chinese Medicine College of Traditional Chinese Medicine Tianjin University of Traditional Chinese Medicine Tianjin 300193 China

Background：Pharmacological therapy for congestive heart failure （CHF） with ventricular arrhythmia is *** the study,our aim was to evaluate the effects of Chinese traditional medicine Shensong Yangxin capsules （SSYX） on heart rhythm and function in CHF patients with frequent ventricular premature complexes （VPCs）.Methods：This double-blind,placebo-controlled,multicenter study randomized 465 CHF patients with frequent VPCs to the SSYX （n =232） and placebo groups （n =233） for 12 weeks of *** primary endpoint was the VPCs monitored by a 24-h ambulatory *** secondary endpoints included the left ventricular ejection fraction （LVEF）,left ventricular end-diastolic diameter,N-terminal pro-brain natriuretic peptide （NT-proBNP）,New York Heart Association （NYHA） classification,6-min walking distance （6MWD）,Minnesota Living with Heart Failure Questionnaire （MLHFQ） scores,and composite cardiac events （CCEs）.Results：The clinical characteristics were similar at *** caused a significantly greater decline in the total number of VPCs than the placebo did （-2145 ± 2848 vs.-841 ± 3411,P 〈 0.05）.The secondary endpoints of the LVEE NYHA classification,NT-proBNP,6MWD,and MLHFQ scores showed a greater improvements in the SSYX group than in the placebo group （ALVEF at 12th week：4.75 ± 7.13 vs.3.30 ± 6.53;NYHA improvement rate at the 8th and 12th week：32.6% vs.21.8%,40.5% vs.25.7%;mean level of NT-proBNP in patients with NT-proBNP 〉125 pg/ml at 12th week：-122 [Q1,Q3：-524,0] vs.-75 [Q1,Q3：-245,0];A6MWD at 12th week：35.1 ± 38.6 vs.17.2 ± 45.6;AMLHFQ at the 4th,8th,and 12th week：-4.24 ± 6.15 vs.-2.31 ± 6.96,-8.l 9 ± 8.41 vs.-3.25 ± 9.40,10.60 ± 9.41 vs.-4.83 ± 11.23,all P 〈 0.05）.CCEs were not different between the groups during the study ***：In this 12-week pilot study,SSYX was demonstrated to have the benefits of VPCs suppression and cardiac function improvement with good compliance on a background of standard treatment for CHF.

关键词： Congestive Heart Failure Randomized ControlledTrial Shensong Yangxin Capsules Ventricular PrematureComplexes

The complex roles of m^(6)A modifications in neural stem cell proliferation, differentiation, and self-renewal and implications for memory and neurodegenerative diseases

在线全文

学校读者我要写书评

暂无评论

Neural Regeneration Research 2025年第6期20卷 1582-1598页

作者： Yanxi Li Jing Xue Yuejia Ma Ke Ye Xue Zhao Fangliang Ge Feifei zheng Lulu Liu Xu Gao Dayong Wang qing Xia Department of Biochemistry and Molecular Biology College of Basic Medical SciencesHarbin Medical UniversityHarbinHeilongjiang ProvinceChina College of Basic Medical Sciences Harbin Medical UniversityHarbinHeilongjiang ProvinceChina Basic Medical Institute Heilongjiang Academy of Medical SciencesHarbinHeilongjiang ProvinceChina Key Laboratory of Heilongjiang Province for Genetically Modified Animals Harbin Medical UniversityHarbinHeilongjiang ProvinceChina Translational Medicine Research and Cooperation Center of Northern China Heilongjiang Academy of Medical SciencesHarbinHeilongjiang ProvinceChina Dongzhimen Hospital Beijing University of Chinese MedicineBeijingChina

N6-methyladenosine(m^(6)A), the most prevalent and conserved RNA modification in eukaryotic cells, profoundly influences virtually all aspects of mRNA metabolism. mRNA plays crucial roles in neural stem cell genesis and neural regeneration, where it is highly concentrated and actively involved in these processes. Changes in m^(6)A modification levels and the expression levels of related enzymatic proteins can lead to neurological dysfunction and contribute to the development of neurological diseases. Furthermore, the proliferation and differentiation of neural stem cells, as well as nerve regeneration, are intimately linked to memory function and neurodegenerative diseases. This paper presents a comprehensive review of the roles of m^(6)A in neural stem cell proliferation, differentiation, and self-renewal, as well as its implications in memory and neurodegenerative diseases. m^(6)A has demonstrated divergent effects on the proliferation and differentiation of neural stem cells. These observed contradictions may arise from the time-specific nature of m^(6)A and its differential impact on neural stem cells across various stages of development. Similarly, the diverse effects of m^(6)A on distinct types of memory could be attributed to the involvement of specific brain regions in memory formation and recall. Inconsistencies in m^(6)A levels across different models of neurodegenerative disease, particularly Alzheimer's disease and Parkinson's disease, suggest that these disparities are linked to variations in the affected brain regions. Notably, the opposing changes in m^(6)A levels observed in Parkinson's disease models exposed to manganese compared to normal Parkinson's disease models further underscore the complexity of m^(6)A's role in neurodegenerative processes. The roles of m^(6)A in neural stem cell proliferation, differentiation, and self-renewal, and its implications in memory and neurodegenerative diseases, appear contradictory. These inconsistencies may be a

关键词： Alzheimer's disease cell self-renewal central nervous system memory microglia nerve regeneration neurodegenerative diseases neurogenesis RNA methylation

A double-blind,randomized,placebo-and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis

在线全文

学校读者我要写书评

暂无评论

Chinese Medical Journal 2020年第24期133卷 2905-2909页

作者： Lin Cai Gen-Hui Chen Qian-Jin Lu Min zheng Yu-Zhen Li Jin Chen Jie zheng Fu-Ren Zhang Jian-Bin Yu Sen Yang Fu-Qiu Li Sheng-Xiang Xiao Qiu-Ning Sun Jin-Hua Xu Xing-Hua Gao Hong Fang Tian-Wen Gao Fei Hao Quan-Zhong Liu Ya-Ting Tu Ruo-Yu Li Bao-Xi Wang Dan-Qi Deng qing-shan zheng Hong-Xia Liu Jian-Zhong Zhang Department of Dermatology Peking University People’s HospitalBeijing 100044China Beijing Wenfeng Tianji Pharma Ltd. Beijing 100044China Department of Dermatology The Second Xiangya HospitalCentral South UniversityChangshaHunan 410011China Department of Dermatology The Second Affiliated Hospital of Zhejiang University School of MedicineHangzhouZhejiang 310009China Department of Dermatology Harbin Medical University Second HospitalHarbinHeilongjiang 150001China Department of Dermatology Sichuan Provincial People’s HospitalChengduSichuan 610072China Department of Dermatology Shanghai JiaoTong University School of Medicine Ruijin HospitalShanghai 213002China shandong Provinical Institute of Dermatology and Venereology JinanShandong 250022China Department of Dermatology The First Affiliated HospitalZhengzhou UniversityZhengzhouHenan 450052China Department of Dermatology The First Affiliated HospitalAnhui Medical UniversityHefeiAnhui 230022China Department of Dermatology The Second Hospital of Jilin UniversityChangchunJilin 130041China Department of Dermatology The Second Affiliated HospitalXi’an Jiaotong UniversityXi’anShaanxi 710004China Department of Dermatology Peking Union Medical College HospitalBeijing 100730China Department of Dermatology Fudan University Huashan HospitalShanghai 200041China Department of Dermatology The First Hospital of China Medical UniversityShenyangLiaoning 110001China Department of Dermatology The First Affiliated HospitalZhejiang UniversityHangzhouZhejiang 310006China Department of Dermatology Xijing HospitalAir Force Medical University of People’s Liberation ArmyXi’anShaanxi 710032China Department of Dermatology Southwest HospitalThird Military Medical University(Army Medical University)Chongqing 400038China Department of Dermatology Tianjin Medical University General HospitalTianjin 300052China Department of Dermatology Wuhan Union HospitalWuhanHubei 430022China Department of Dermatology Peking University First HospitalBeijing

Background:Benvitimod cream,a novel synthetic small molecule,was effective in treating mild-to-moderate plaque *** conducted a phase III clinical trial to assess the efficacy and safety of benvitimod cream in patients with mild-to-moderate plaque ***:We randomly assigned 686 patients(2:1:1)to receive 1%benvitimod cream,0.005%calcipotriol ointment or placebo twice a day for 12 *** primary efficacy end points were the percentage of patients with a 75%or greater reduction from baseline in the psoriasis area and severity index(PASI 75)score and with a score of 0 or 1 in static physician’s global assessment(sPGA)at week ***:The results showed that 50.4%of patients in the benvitimod group achieved PASI 75,which was significantly higher than that in the calcipotriol(38.5%,P<0.05)and placebo(13.9%,P<0.05)*** proportion of patients achieving an sPGA score 0 or 1 was 66.3%in the benvitimod group and 63.9%in the calcipotriol group,which were both significantly higher than that in the placebo group(34%,P<0.05).In the long-term follow-up study,50.8%of patients experienced *** retreatment with 1%benvitimod,73.3%of patients achieved an sPGA score of 0 or 1 again at week *** events included application site irritation,follicular papules,and contact *** systemic adverse reactions were ***:During this 12-week study,benvitimod cream was demonstrated with high effectiveness and safety in patients with mild-to-moderate plaque psoriasis.

关键词： Psoriasis Benvitimod Immune modulator Drug discovery 3,5-dihydroxy-4-isopropylstilbene

金钗石斛根际可培养细菌多样性及抑菌活性研究

在线全文

学校读者我要写书评

暂无评论

云南大学学报（自然科学版） 2018年第3期40卷 586-602页

作者：安忠琦詹伟吴庆珊方正王玉倩余天华翁庆北贵州师范大学生命科学学院贵州贵阳550001

根际土壤微生物对植物根系发育和植物生长具有重要促进作用.为探究金钗石斛根际土壤细菌的多样性,利用稀释涂布平板法和16S r DNA序列分析技术,对贵州贵阳、金沙和赤水三地栽培的金钗石斛根际土壤中的细菌进行分离和初步鉴定.同时,通过... 详细信息

根际土壤微生物对植物根系发育和植物生长具有重要促进作用.为探究金钗石斛根际土壤细菌的多样性,利用稀释涂布平板法和16S r DNA序列分析技术,对贵州贵阳、金沙和赤水三地栽培的金钗石斛根际土壤中的细菌进行分离和初步鉴定.同时,通过双层平板打孔法和对峙培养法筛选具抑菌活性菌株.结果表明,从金钗石斛根际土壤共分离了1010株细菌,包括67个OTUs,隶属于厚壁菌门(Firmicutes)、变形菌门α亚群(aProteobacteria)、变形菌门β亚群(β-Proteobacteria)、变形菌门γ亚群(γ-Proteobacteria)、拟杆菌门(Bacteroidetes)和放线菌门(Actinobacteria)的32个属.其中厚壁菌门(54.5%),芽孢杆菌属(Bacillus,44.5%)为优势类群.不同地栽培的金钗石斛根际土壤细菌群落组成存在差异,shannon-Wiener指数为2.80~2.94.此外,通过筛选共获得23株抑菌活性菌株,其中,JCSHGTTB03-24和CYSHGTR2A05-20两株菌对多种植物病原菌具抑菌活性.金钗石斛根际土壤细菌具丰富的多样性和潜在的生物活性.研究为今后金钗石斛栽培和农业生物防治提供了宝贵的微生物资源.

关键词：金钗石斛根际细菌土壤多样性抑菌活性

在线全文

学校读者我要写书评

暂无评论

压电材料在反问题中应用的进展

上海交通大学学报 1999年第10期33卷 1317-1321,1328页

作者：李山青刘正兴章建国上海交通大学工程力学系上海200030

回顾压电材料在反问题中的应用．从大量的文献中，总结了通过反分析，将压电材料应用在参数辨识、损伤鉴别、外力测量以及变形监测等问题中的研究手段和成果，并预测了今后的研究方向．利用压电材料进行损伤监测将成为研究的重点。

关键词：压电材料反问题估测无损检测振动估测

Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1:interim analysis of the randomized,controlled,phase 3,non-inferiority TALENT study

在线全文

学校读者我要写书评

暂无评论

Chinese Medical Journal 2020年第24期133卷 2919-2927页

作者： Bin Su Cheng Yao qing-Xia Zhao Wei-Ping Cai Min Wang Hong-Zhou Lu Yuan-Yuan Chen Li Liu Hui Wang Yun He Yu-Huang zheng Ling-Hua Li Jin-Feng Chen Jian-Hua Yu Biao Zhu Min Zhao Yong-Tao Sun Wen-Hui Lun Wei Xia Li-Jun Sun Li-Li Dai Tai-Yi Jiang Mei-Xia Wang qing-shan zheng Hai-Yan Peng Yao Wang Rong-Jian Lu Jian-Hua Hu Hui Xing Yi-Ming Shao Dong Xie Tong Zhang Fu-Jie Zhang Hao Wu TALENT Study Team Center for Infectious Diseases Beijing Youan HospitalCapital Medical UniversityBeijing 100069China Frontier Biotechnologies Inc. NanjingJiangsu 211122China Department of Infectious Diseases Infectious Disease Hospital of Henan ProvinceZhengzhouHenan 450061China Infectious Disease Center Guangzhou Eighth People’s HospitalGuangzhou Medical UniversityGuangzhouGuangdong 510060China Institute of HIV/AIDS The First Hospital of ChangshaChangshaHunan 410005China Department of Infectious Diseases Shanghai Public Health Clinical CenterFudan UniversityShanghai 201508China Department of Infectious Diseases National Clinical Center for Infectious DiseasesShenzhen Third People’s HospitalShenzhenGuangdong 518112China Department of Infectious Diseases The Second Xiangya HospitalCentral South UniversityChangshaHunan 410011China Department of Infectious Diseases Xixi Hospital of HangzhouHangzhouZhejiang 310023China State Key Laboratory for Diagnosis and Treatment of Infectious Diseases National Clinical Research Center for Infectious DiseasesThe First Affiliated HospitalZhejiang UniversityHangzhouZhejiang 310003China National Clinical Research Center for Infectious Diseases the Fifth Medical Center of PLA General HospitalBeijing 100039China Department of Infectious Diseases Tangdu HospitalThe Fourth Military Medical UniversityXi’anShaanxi 710038China Clinical and Research Center of Infectious Diseases Beijing Ditan HospitalCapital Medical UniversityBeijing 100015China Center for Drug Clinical Research Shanghai University of Traditional Chinese MedicineShanghai 201203China Beijing Co-CRO Medical Development Co. Ltd.Beijing 100711China State Key Laboratory for Infectious Disease Prevention and Control National Center for AIDS/STD Control and PreventionChinese Center for Disease Control and PreventionBeijing 102206China 不详

Background:Albuvirtide is a once-weekly injectable human immunodeficiency virus(HIV)-1 fusion *** present interim data for a phase 3 trial assessing the safety and efficacy of albuvirtide plus lopinavir-ritonavir in HIV-1-infected adults already treated with antiretroviral ***:We carried out a 48-week,randomized,controlled,open-label non-inferiority trial at 12 sites in *** on the World Health Organization(WHO)-recommended first-line treatment for>6 months with a plasma viral load>1000 copies/mL were enrolled and randomly assigned(1:1)to receive albuvirtide(once weekly)plus ritonavir-boosted lopinavir(ABT group)or the WHO-recommended second-line treatment(NRTI group).The primary endpoint was the proportion of patients with a plasma viral load below 50 copies/mL at 48 ***-inferiority was prespecified with a margin of 12%.Results:At the time of analysis,week 24 data were available for 83 and 92 patients,and week 48 data were available for 46 and 50 patients in the albuvirtide and NRTI groups,*** 48 weeks,80.4%of patients in the ABT group and 66.0%of those in the NRTI group had HIV-1 RNA levels below 50 copies/mL,meeting the criteria for *** the per-protocol population,the superiority of albuvirtide over NRTI was *** frequency of grade 3 to 4 adverse events was similar in the two groups;the most common adverse events were diarrhea,upper respiratory tract infections,and grade 3 to 4 increases in triglyceride *** function was significantly more impaired at 12 weeks in the patients of the NRTI group who received tenofovir disoproxil fumarate than in those of the ABT ***:The TALENT study is the first phase 3 trial of an injectable long-acting HIV *** interim analysis indicates that once-weekly albuvirtide in combination with ritonavir-boosted lopinavir is well tolerated and non-inferior to the WHO-recommended second-line regimen in patients with first-line treatme

关键词： HIV Fusion inhibitor Albuvirtide LPV/r Phase 3 clinical trial

在线全文

学校读者我要写书评

暂无评论

校园网IP地址管理中的几种策略与实现

苏州大学学报（自然科学版） 2004年第1期20卷 47-50页

作者：张庆鲁征山苏州大学计算机与网络管理中心江苏苏州215006

主要叙述了校园网IP地址管理中用到的几种策略:VLAN技术、内部地址分配、双出口环境中代理服务器地址的设置和其中运用的策略路由技术以及由此扩展开的国际大流量主机的地址转换,并介绍了这些策略的实现方法.

关键词：校园网 IP地址管理虚拟局域网静态地址转换动态地址转换访问控制

聚氧乙烯型非离子表面活性剂类农药助剂的环境行为特性综述

在线全文

学校读者我要写书评

暂无评论

农业资源与环境学报 2017年第3期34卷 197-206页

作者：孔祥吉韦笑王娜卜元卿单正军环境保护部南京环境科学研究所江苏南京210042 国家环境保护农药环境评价与污染控制重点实验室江苏南京210042 南京信息工程大学江苏南京210044

聚氧乙烯型非离子表面活性剂烷基酚聚氧乙烯醚(APEOs)、醇基聚氧乙烯醚(AEOs)以及烷基胺聚氧乙烯醚(ANEOs)是几类典型的农药助剂,其环境行为特性主要体现在分配系数、土壤吸附性和降解性等参数上。这些化合物主要的环境问题在于其部分... 详细信息

聚氧乙烯型非离子表面活性剂烷基酚聚氧乙烯醚(APEOs)、醇基聚氧乙烯醚(AEOs)以及烷基胺聚氧乙烯醚(ANEOs)是几类典型的农药助剂,其环境行为特性主要体现在分配系数、土壤吸附性和降解性等参数上。这些化合物主要的环境问题在于其部分代谢物的环境风险较高。本文基于几类聚氧乙烯型非离子表面活性剂助剂的结构特征,综述了其在环境中的分布、归趋及对环境的影响。

关键词：非离子表面活性剂环境分布生物降解

Potential neuroprotection by Dendrobium nobile Lindl alkaloid in Alzheimer's disease models

在线全文

学校读者我要写书评

暂无评论

Neural Regeneration Research 2022年第5期17卷 972-977页

作者： Dai-Di Li Chang-qing zheng Feng Zhang Jing-shan Shi Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Lab of Ethnomedicine of Ministry of Education Zunyi MedicalUniversityZunyiGuizhou ProvinceChina School of Pharmacy Shanghai University of Traditional Chinese MedicineShanghaiChina

At present,treatments for Alzheimer's disease can temporarily relieve symptoms but cannot prevent the decline of cognitive ability and other neurodegenerative *** nobile Lindl alkaloid is the main active component of Dendrobium nobile *** nobile Lindl alkaloid has been shown to resist aging,prolong life span,and exhibit immunomodulatory effects in *** review summarizes the mechanisms behind the neuroprotective effects reported in Alzheimer's disease animal *** neuroprotective effects of Dendrobium nobile Lindl alkaloid have not been studied in *** mechanisms by which Dendrobium nobile Lindl alkaloid has been reported to improve cognitive dysfunction in Alzheimer's disease animal models may be associated with extracellular amyloid plaque production,regulation of tau protein hyperphosphorylation,inhibition of neuroinflammation and neuronal apoptosis,activation of autophagy,and enhanced synaptic connections.

关键词： Alzheimer's disease amyloidβplaques animal models Dendrobium